Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model

Nature Reviews Drug Discovery

Volumn 3, Issue 1, 2004, Pages 27-41

  Norman, Anthony W ^a   Mizwicki, Mathew T ^a   Norman, Derek P G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALFACALCIDOL; ANDROGEN; BRASSINOLIDE; BRASSINOSTEROID; CELL NUCLEUS RECEPTOR; ECDYSONE; ESTRADIOL; ETHINYLESTRADIOL; GLUCOCORTICOID; HYDROCORTISONE; LIOTHYRONINE; MEMBRANE RECEPTOR; MINERALOCORTICOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROGESTERONE; RETINOIC ACID; RETINOID; STEROID HORMONE; STEROID RECEPTOR; TESTOSTERONE; THYROID HORMONE; VITAMIN D;

ANIMAL CELL; BINDING AFFINITY; CAVEOLA; CELL MEMBRANE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DRUG RECEPTOR BINDING; DRUG TARGETING; GENOMICS; HORMONE ACTION; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION;

EID: 0345874610     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1283     Document Type: Review

References (118)

1. Norman, A. W. & Litwack, G. L. Hormones (Academic, San Diego, 1997).
2. Krausz, C. et al. Intracellular calcium increase and acrosome reaction if response to progesterone in human spermatozoa are correlated with in vitro. Human Reprod. 10, 120-124 (1995).
3. Meizel, S., Turner, K. O. & Nuccitelli, R. Progesterone triggers a wave of increased free calcium during the human sperm acrosome reaction. Dev. Biol. 182, 67-75 (1997).
4. 3 regulates chondrocyte matrix vesicle protein kinase C (PKC) directly vis G-protein-dependent mechanisms and indirectly via incorporation of PKC during matrix vesicle biogenesis. J. Biol. Chem. 277, 11828-11837 (2002).
5. Selye, H. Correlations between the chemical structure and the pharmacological actions of the steroids. Endocrinology 30, 437-453 (1942).
6. Klein, K. & Henk, K. Klinisch-experimentelle untersuchungen uber den einfluss von aldosteron auf haemodynamik and gerinnung. Z. Kreisl. Forsch. 40-53 (1964).
7. Spach, C. & Streeten, D. H. Retardation of sodium exchange in dog erythrocytes by physiological concentrations of aldosterone, in vitro. J. Clin. Invest. 43, 217-227 (1963).
8. Jensen, E. V., De Sombre, E. R. & Jungblut, P. W. Interaction of estrogens with receptor sites in vivo and in vitro. Proc. Sec. Int. Cong. 132, 492-500 (1966).
9. Toft, D. & Gorski, J. A receptor molecule for estrogens: Isolation from the rat uterus and preliminary characterization. Proc. Natl Acad. Sci. USA 55, 1574-1581 (1966).
10. Li, J. & Chory, J. A putative leucine-rich repeat receptor kinase involved in brassinosteroid signal transduction. Cell 90, 929-938 (1997).
11. Walters, M. R., Hunziker, W. & Norman, A. W. A mathematical model describing the subcellular localization of non-membrane bound steroid, seco-steroid, and thyronine receptors. J. Steroid Biochem. Mol. Biol. 15, 491-495 (1981).
12. Hermanson, O., Glass, C. K. & Rosenfeld, M. G. Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol. Metab. 13, 55-60 (2002).
13. McKenna, N. J. & O'Malley, B. W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108, 465-474 (2002).
14. Altucci, L. & Gronemeyer, H. Nuclear receptors in cell life and death. Trends Endocrinol. Metab. 12, 460-468 (2001).
15. Moras, D. & Gronemeyer, H. The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10, 384-391 (1998).
16. Weatherman, R. V., Fletterick, R. J. & Scanlon, T. S. Nuclear receptor ligands and ligand-binding domains. Annu. Rev. Biochem. 68, 559-582 (1999).
17. Bourguet, W., Germain, P. & Gronemeyer, H. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol. Sci. 21, 381-388 (2000).
18. Egea, P. F., Klaholz, B. P. & Moras, D. Ligand-protein interactions in nuclear receptors of hormones. FEBS Lett. 476, 62-67 (2000).
19. Haussler, M. R. & Norman A. W. Chromosomal receptor for a vitamin D metabolite. Proc. Natl Acad. Sci. USA 62, 155-162 (1969).
20. Bogan, A. A., Cohen, F. E. & Scanlan, T. S. Natural ligands of nuclear receptors have conserved volumes. Nature Struct. Biol. 5, 679-681 (2003).
21. 3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological analogs are preferred for genomic biological responses. Mol. Endocrinol. 11, 1518-1531 (1997).
22. 3. Steroids 67, 457-466 (2002).
23. Kousteni, S. et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298, 843-846 (2002).
24. Kousteni, S. et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104, 719-730 (2001).
25. Swann, S. L. et al. Structure-based design of selective agonists for a rickets-associated mutant of the vitamin D receptor. J. Am. Chem. Soc. 124, 13795-13805 (2002).
26. Sun, J. et al. Antagonists selective for estrogen receptor-α. Endocrinology 143, 941-947 (2002).
27. 3 analogs which selectively restore activity to a vitamin D receptor mutant associated with rickets. Org. Lett. 4, 3863-3866 (2002).
28. Anderson, R. G. & Jacobson, K. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296, 1821-1825 (2002).
29. Razani, B., Woodman, S. E. & Lisanti, M. P. Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 54, 431-467 (2002).
30. He, Z. et al. Perception of brassinosteroids by the extracellular domain of the receptor kinase BRI1. Science 288, 2360-2363 (2000).
31. Zhu, Y. et al. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc. Natl Acad. Sci. USA 100, 2231-2236 (2003).
32. Zhu, Y., Bond, J. & Thomas, P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc. Natl Acad. Sci USA 100, 2237-2242 (2003).
33. Chambliss, K. L. et al. ERβ has nongenomic action in caveolae. Mol. Endocrinol. 16, 938-946 (2002).
34. Song, R. X. et al. Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol. Endocrinol. 16, 116-127 (2002).
35. 3 is present in an intestinal caveolae membrane fraction. Biochem. Biophys. Res. Commun. 298, 414-419 (2002).
36. Barbato, J. C., Mulrow, P. J., Shapiro, J. I. & Franco-Saenz, R. Rapid effects of aldosterone and spironolactone in the isolated working rat heart. Hypertension 40, 130-135 (2002).
37. 3 binding by vitamin D receptor present in caveolae enriched fraction of chick and wild type mouse duodenum, lung and kidney but not comparable VDR-knockout tissues. J. Steroid Biochem. Mol. Biol. (in the press).
38. α subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. J. Biol. Chem. 271, 29182-29190 (1996).
39. Razandi, M. et al. Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol. Cell. Biol. 23, 1633-1646 (2003).
40. a. J. Biol. Chem. 276, 27071-27076 (2001).
41. Razandi, M., Pedram, A., Park, S. T. & Levin, E. R. Proximal events in signaling by plasma membrane estrogen receptors. J. Biol. Chem. 278, 2701-2712 (2003).
42. Castoria, G. et al. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J. Cell Biol. 161, 547-556 (2003).
43. Rosner, W. et al. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J. Steroid Biochem. Mol. Biol. 69, 481-485 (1999).
44. DiMartino, S. J., Shah, A. B., Trujillo, G. & Kew, R. R. Elastase controls the binding of the vitamin D-binding protein (Gc-globulin) to neutrophils: A potential role in the regulation of C5α co-chemotactic activity. J. Immunol. 166, 2688-2694 (2001).
45. Harvey, B. J. et al. Non-genomic convergent and divergent signalling of rapid responses to aldosterone and estradiol in mammalian colon. Steroids 67, 483-491 (2003).
46. 3. J. Biol. Chem. 270, 6639-6643 (1995).
47. Stubbs, C. D., Slater, S. J., Okamura, W. H. & Norman, A. W. in Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone (eds Norman, A. W., Bouillon, R. & Thomasset, M) 339-346 (University of California Riverside, Riverside, 1997).
48. Bourget, W. et al. Crystal structure of the ligand-binding domain of the human nuclear receptor RXRα. Nature 375, 377-382 (1995).
49. Renaud, J. P. et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689 (1995).
50. Willson, T. M. & Moore, J. T. Genomics verus orphan nuclear receptors: a half-time report. Mol. Endocrinol. 16, 1135-1144 (2002).
51. Kliewer, S. A., Lehmann, J. M. & Willson, T. M. Orphan nuclear receptors: shifting endocrinology into reverse. Science 284, 757-760 (1999).
52. Brzozowski, A. M. et al. Molecular basis of agonism and antagonism of the oestrogen receptor. Nature 389, 753-758 (1997).
53. Gibbs, P. E. M. & Dugaiczyk, A. Origin of structural domains of the serum albumin gene family and a predicted structure of the gene for vitamin D binding protein. Mol. Biol. Evol. 4, 364-379 (1987).
54. 3, the plasma vitamin D binding protein, and their ligands. J. Bone Miner. Res. 18, 795-806 (2003).
55. Grishkovskaya, I. et al. Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain. EMBO J. 19, 504-512 (2000).
56. Hammond, G. L., Awakumov, G. V. & Muller, Y. A. Structure/function analyses of human sex hormone-binding globulin: effects of zinc on steroid-binding specificity. J. Steroid Biochem. Mol. Biol. 85, 195-200 (2003).
57. Mizwicki, M. T., Norman, D. P. G. & Norman, A. W. Vitamin D receptor [VDR] ligand binding: conformational ensembles explain both genomic and rapid responses. J. Steroid Biochem. Mol. Biol. (in the press).
58. Wagner, R. L. et al. A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697 (1995).
59. Fischer, E. Einfluss der configuration auf die wirkung der enzyme. Ber. Dtsch. Chem. Ges. 27, 2985-2993 (1894).
60. Koshland, D. E. Jr. Application of a theory of enzyme specificity to protein synthesis. Proc. Natl Acad. Sci. USA 44, 98-104 (1958).
61. Bursavich, M. G. & Rich, D. H. Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles. J. Med. Chem. 45, 541-558 (2002).
62. Lu, G. W. Molecular mechanisms underlying gating activity of voltage dependent ion channels. Sheng Li Ke. Xue. Jin. Zhan. 28, 306-310 (1997).
63. Catterall, W. A. Molecular mechanisms of gating and drug block of sodium channels. Novartis Found. Symp. 241, 206-218 (2002).
64. Northrup, S. H. & McCammon, J. A. Gated reactions. J. Am. Chem. Soc. 106, 930-934 (1984).
65. Sadja, R., Smadja, K., Alagem, N. & Reuveny, E. Coupling Gβγ-dependent activation to channel opening via pore elements in inwardly rectifying potassium channels. Neuron 29, 669-680 (2001).
66. Bond, P. J., Faraldo-Gomez, J. D. & Sansom, M. S. OmpA: a pore or not a pore? Simulation and modeling studies. Biophys. J. 83, 763-775 (2002).
67. Knowles, J. & Gromo, G. Target selection in drug discovery. Nature Rev. Drug Disov. 2, 63-69 (2003).
68. Pietras, R. J. & Szego, C. M. Endometrial cell calcium and oestrogen action. Nature 265, 69-72 (1975).
69. Valverde, M. A. et al. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the β subunit. Science 285, 1929-1931 (1999).
70. Simonici, T. et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407, 538-541 (2000).
71. Razandi, M., Pedram, A. & Levin, E. R. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol. Endocrinol. 14, 1434-1447 (2000).
72. Benten, W. P. et al. Functional testosterone receptors in plasma membranes of T cells. FASEB J. 13, 123-133 (1999).
73. 2+ influx via non-genomic surface receptors in activated T cells. FEBS Lett. 407, 211-214 (1997).
74. Liberherr, M. & Grosse, B. Androgens increase intracellular calcium concentration and inositol 1, 4, 5-triphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J. Biol. Chem. 269, 7217-7223 (1994).
75. Migliaccio, A. et al. Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J. 19, 5406-5417 (2000).
76. Estrada, M., Espinosa, A., Muller, M. & Jaimovich, E. Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells. Endocrinology 144, 3586-3597 (2003).
77. Bagowski, C. P., Myers, J. W. & Ferrell, J. E. Jr. The classical progesterone receptor associates with p42 MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes. J. Biol. Chem. 276, 37708-37714 (2001).
78. ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17, 2008-2018 (1998).
79. Ballare, C. et al. Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Mol. Cell Biol. 23, 1994-2008 (2003).
80. 3 of whole cell chloride currents in osteoblastic ROS 17/2. 8 cells: a structure-function study. J. Biol. Chem. 272, 22617-22622 (1997).
81. 3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. J. Biol. Chem. 264, 20265-20274 (1989).
82. 3 on growth plate chondrocytes. J. Cell. Physiol. 176, 516-524 (1998).
83. 3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ. Res. 91, 17-24 (2002).
84. 2+ concentration in pancreatic β-cells through nongenomic signal transduction. Endocrinology 140, 4706-4712 (1999).
85. Zeitz, U. et al. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 17, 509-511 (2003).
86. 3 is independent of nuclear receptor binding. J. Biol. Chem. 270, 15962-15965 (1995).
87. 3 in promyelocytic NB4 leukemia cells: a structure-function study. Endocrinology 139, 457-465 (1998).
88. Qiu, J. et al. Nongenomic mechanisms of glucocorticoid inhibition of nicotine-induced calcium influx in PC12 cells: involvement of protein kinase C. Endocrinology 139, 5103-5108 (1998).
89. Orchinik, M., Murray, T. F. & Moore, F. L. A corticosteroid receptor in neuronal membranes. Science 252, 1848-1851 (1991).
90. Lin, H. Y., Thacorf, H. R., Davis, F. B. & Davis, P. J. Protentiation by thyroxine of interferon-γ-induced antiviral state requires PKA and PKC activities. Am. J. Physiol. Cell Physiol. 271, C1256-C1261 (1996).
91. Sun, Z. Q. et al. Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes. Am. J. Physiol. Endocrinol. Metab. 278, E302-E307 (2000).
92. Davis, P. J. & Davis, F. B. Nongenomic actions of thyroid hormone on the heart. Thyroid 12, 459-466 (2002).
93. Watson, C. S. & Gametchu, B. Membrane-initiated steroid actions and the proteins that mediate them. Proc. Soc. Exp. Biol. Med. 220, 9-19 (1999).
94. Falkenstein, E. et al. Multiple actions of steroid hormones - a focus on rapid non-genomic effects. Pharmacol. Rev. 53, 513-555 (2000).
95. Harvey, B. J., Condliffe, S. B. & Doolan, C. M. Sex and salt hormones: rapid effects in epithelia. News Physiol. Sci. 16, 174-177 (2001).
96. Cato, A. C., Nestl, A. & Mink, S. Rapid actions of steroid receptors in cellular signaling pathways. Science STKE [online], (cited 5 Dec 2003), (2002).
97. Levin, E. R. Cellular functions of plasma membrane estrogen receptors. Steroids 67, 471-475 (2002).
98. Losel, R. M. et al. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83, 965-1016 (2003).
99. Wong, C. W. et al. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc. Natl Acad. Sci. USA 99, 14783-14788 (2002).
100. Bettoun, D. J. et al. A vitamin D receptor-Ser/Thr phophatase-p70 S6 kinase complex and modulation of its enzymatic activities by the ligand. J. Biol. Chem. 277, 24847-24850 (2002).
101. Evans, S. J., Murray, T. F. & Moore, F. L. Partial purification and biochemical characterization of a membrane glucocorticoid receptor from an amphibian brain. J. Steroid Biochem. Mol. Biol. 72, 209-221 (2000).
102. Powell, C. E., Watson, C. S. & Gametchu, B. Immunoaffinity isolation of native membrane glucocorticoid receptor from S49++lymphoma cells: biochemical characterization and interaction with Hsp 70 and Hsp 90. Endocrine 10, 271-280 (1999).
103. 3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J. Biol. Chem. 269, 23750-23756 (1994).
104. Nemere, I., Ray, R. & McManus, W. Immunochemical studies on the putative plasmalemmal rceeptor for 1, 25(OH)(2)D(3). I. Chick intestine. Am. J. Physiol. Endocrinol. Metab. 278, E1104-E1114 (2000).
105. 3 in osteoblast. Steroids 67, 235-246 (2002).
106. Luconi, M. et al. Characterization of membrane nongenomic receptors for progesterone in human spermatozoa. Steroids 67, 505-509 (2002).
107. Norfleet, A. M., Thomas, M. L., Gametchu, B. & Watson, C. S. Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 140, 3805-3814 (1999).
108. Benten, W. P., Stephan, C., Lieberherr, M. & Wunderlich, F. Estradiol signaling via sequestrable surface receptors. Endocrinology 142, 1669-1677 (2001).
109. Lutz, L. B. et al. Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol. Endocrinol. 17, 1106-1116 (2003).
110. Pietras, R. J. & Szego, C. M. Specific binding site for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265, 69-72 (1977).
111. Moore, F. L., Orchinik, M. & Lowry, C. Functional studies of corticosterone receptors and neuronal membranes. Receptor 5, 28 (1995).
112. Christ, M., Sippel, K., Eisen, C. & Wehling, M. Non-classical receptors for aldosterone in plasma membranes from pig kidneys. Mol. Cell. Endocrinol. 99, R31-R34 (1994).
113. Kampa, M. et al. The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton. FASEB J. 16, 1429-1431 (2002).
114. Norfleet, A. M., Clarke, C. H., Gametchu, B. & Watson, C. S. Antibodies to the estrogen rceeptor-α modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors. FASEB J. 14, 157-165 (2000).
115. DiMartino, S. J. & Kew, R. R. Initial characterization of the vitamin D binding protein (Gc-globulin) binding site on the neutrophil plasma membrane: evidence for a chondroitin sulfate proteoglycan. J. Immunol. 163, 2135-2142 (1999).
116. Rochel, N. et al. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell 5, 173-179 (2000).
117. Verboven, C. et al. A structural basis for the unique binding features of the human vitamin D-binding protein. Nature Struct. Biol. 9, 131-136 (2002).
118. 3 act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses. Steroids 66, 147-158 (2001).